Heltweg Birgit, Dequiedt Franck, Marshall Brett L, Brauch Carsten, Yoshida Minoru, Nishino Norikazu, Verdin Eric, Jung Manfred
Department of Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität Münster, Hittorfstrasse 58-62, 48149 Münster, Germany.
J Med Chem. 2004 Oct 7;47(21):5235-43. doi: 10.1021/jm0497592.
To probe the steric requirements for deacylation, we synthesized lysine-derived small molecule substrates and examined structure-reactivity relationships with various histone deacetylases. Rat liver, human HeLa, and human recombinant class I and II histone deacetylases (HDACs) as well as human recombinant NAD(+)-dependent SIRT1 (class III enzyme) were used in these studies. A benzyloxycarbonyl substituent on the alpha-amino group yielded the highest conversion rates. Replacing the epsilon-acetyl group with larger lipophilic acyl substituents led to a pronounced decrease in conversion by class I and II enzymes; the class III enzyme displayed a greater tolerance. Incubations with recombinant FLAG-tagged human HDACs 1, 3, and 6 showed a distinct subtype selectivity among small molecule substrates. The subtype selectivity of HDAC inhibitors could be predicted with these substrates and an easily obtainable mixture of HDAC subtypes.
为了探究去酰化的空间要求,我们合成了赖氨酸衍生的小分子底物,并研究了与各种组蛋白脱乙酰酶的结构-反应性关系。这些研究中使用了大鼠肝脏、人类HeLa细胞以及人类重组I类和II类组蛋白脱乙酰酶(HDAC),还有人类重组NAD(+)依赖性SIRT1(III类酶)。α-氨基上的苄氧羰基取代基产生了最高的转化率。用较大的亲脂性酰基取代基取代ε-乙酰基导致I类和II类酶的转化率显著降低;III类酶表现出更大的耐受性。用重组FLAG标签的人类HDAC 1、3和6进行孵育,结果显示小分子底物之间存在明显的亚型选择性。HDAC抑制剂的亚型选择性可以通过这些底物和易于获得的HDAC亚型混合物来预测。